NNVC
Income statement / Annual
Last year (2025), NanoViricides, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, NanoViricides, Inc.'s net income was -$9.47 T.
See NanoViricides, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$759.01 K
|
$747.53 K
|
$723.33 K
|
$704.54 K
|
$699.72 K
|
$695.91 K
|
$680.06 K
|
$662.95 K
|
$659.55 K
|
| Gross Profit |
$0.00
|
-$759.01 K
|
-$747.53 K
|
-$723.33 K
|
-$704.54 K
|
-$699.72 K
|
-$695.91 K
|
-$680.06 K
|
-$662.95 K
|
-$659.55 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.55 T
|
$5.44 M
|
$6.39 M
|
$5.78 M
|
$6.11 M
|
$4.70 M
|
$5.92 M
|
$4.83 M
|
$5.53 M
|
$5.03 M
|
| General & Administrative Expenses |
$4.04 T
|
$3.08 M
|
$2.55 M
|
$2.33 M
|
$2.63 M
|
$3.30 M
|
$2.74 M
|
$4.50 M
|
$4.07 M
|
$3.83 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.04 T
|
$3.08 M
|
$2.55 M
|
$2.33 M
|
$2.63 M
|
$3.30 M
|
$2.74 M
|
$4.50 M
|
$4.07 M
|
$3.83 M
|
| Other Expenses |
$0.00
|
-$759.01 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$9.59 T
|
$7.76 M
|
$8.94 M
|
$8.11 M
|
$8.74 M
|
$8.00 M
|
$8.66 M
|
$9.33 M
|
$9.60 M
|
$8.86 M
|
| Cost And Expenses |
$0.00
|
$8.52 M
|
$8.94 M
|
$8.11 M
|
$8.74 M
|
$8.00 M
|
$8.66 M
|
$9.33 M
|
$9.60 M
|
$8.86 M
|
| Interest Income |
$124.83 B
|
$271.77 K
|
$355.83 K
|
$11.86 K
|
$9.35 K
|
$17.08 K
|
$55.50 K
|
$100.43 K
|
$60.96 K
|
$62.64 K
|
| Interest Expense |
$149.00 M
|
$49.81 K
|
$938.00
|
$5.12 K
|
$85.41 K
|
$93.67 K
|
$0.00
|
$544.49 K
|
$2.13 M
|
$2.47 M
|
| Depreciation & Amortization |
$0.00
|
$759.01 K
|
$747.53 K
|
$723.33 K
|
$704.54 K
|
$699.72 K
|
$695.91 K
|
$680.06 K
|
$662.95 K
|
$659.55 K
|
| EBITDA |
-$9.59 T |
-$7.49 M |
-$7.84 M |
-$7.38 M |
-$8.03 M |
-$7.30 M |
-$7.96 M |
-$8.59 M |
-$8.94 M |
-$8.20 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$124.68 B
|
$221.97 K
|
$354.90 K
|
$6.74 K
|
-$78.08 K
|
-$5.45 M
|
$235.24 K
|
$761.71 K
|
-$703.77 K
|
-$1.87 M
|
| Income Before Tax |
-$9.47 T
|
-$8.29 M
|
-$8.59 M
|
-$8.11 M
|
-$8.82 M
|
-$13.45 M
|
-$8.42 M
|
-$8.56 M
|
-$10.30 M
|
-$10.72 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$179.75 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$9.47 T
|
-$8.29 M
|
-$8.59 M
|
-$8.10 M
|
-$8.82 M
|
-$13.40 M
|
-$8.24 M
|
-$8.56 M
|
-$10.30 M
|
-$10.72 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.63 |
-0.7 |
-0.74 |
-0.7 |
-0.81 |
-2.39 |
-2.3 |
-2.64 |
-3.43 |
-3.72 |
| EPS Diluted |
-0.63 |
-0.7 |
-0.74 |
-0.7 |
-0.81 |
-2.39 |
-2.3 |
-2.64 |
-3.43 |
-3.72 |
| Weighted Average Shares Out |
$15.12 M
|
$11.87 M
|
$11.63 M
|
$11.53 M
|
$10.90 M
|
$5.62 M
|
$3.59 M
|
$3.25 M
|
$3.01 M
|
$2.88 M
|
| Weighted Average Shares Out Diluted |
$15.12 M
|
$11.87 M
|
$11.63 M
|
$11.53 M
|
$10.90 M
|
$5.62 M
|
$3.59 M
|
$3.25 M
|
$3.01 M
|
$2.88 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
